Menu Menu

IOVA    Iovance Biotherapeutics Inc    1425205    
Income Statement
Revenue iova-20241231x10k 164,070,000
Net Income iova-20241231x10k -372,177,000
Profit Margin -226.84%

Balance Sheet
Current Assets 457,018,000
Assets 910,426,000
Current Liabilities 122,341,000
Liabilities 200,021,000
Equity 710,405,000
Shares Out 303,514,000

Cash Flow Statement
Operating Cash Flow -352,977,000
Investing Cash Flow -96,411,000

Market Analysis
Market Cap 3,153,508,486
Price 3.59
BVPS 2.34
PB 1.50
EPS -1.68
PS 4.81
FCF -449,388,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/27 -1.28
Apr May Jun
5/09 -0.42
Jul Aug Sep
8/08 -0.34
Oct Nov Dec
11/05

Find a discrepancy? The most accurate way to find company fundamental data is to view IOVA documents filed with the SEC.


IOVA Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas